The report covers the Current scenario and the future growth prospects of the ‘3D Bioprinting Market from 2018-2027. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
Pune, India -- (SBWIRE) -- 06/29/2018 -- The Global 3D Bio-Printing Market is expected to grow at an approximate CAGR of 25% during the forecast period 2018-2023.
3D bio-printing involves the identification of the key architectural and compositional elements of a target tissue, and then creating a design that can be utilized by a bio-printer so as to generate that tissue in a laboratory environment. The technique is driving innovation in many areas of medicine, engineering, education, and others. 3D bio-printing is being applied to regenerative medicine to address the need for tissues and organs suitable for transplantation, which is driving the market growth along with the increasing healthcare expenditure. Technical challenges related to the sensitivities of living cells and the construction of tissues, lack of skilled labours and awareness may restrain the market growth during the forecast period.
3D Bioprinting Market - Key Players
There are some of the key players for the global 3D bio-printing market: ORGANOVO HOLDINGS, INC. (U.S.), CELLINK AB (Sweden), Bio3D Technologies (Singapore), Aspect Biosystems Ltd. (Canada), Stratasys Ltd. (U.S.), Materialise (U.S.), FATHOM (U.S.), Allevi (U.S.), ENVISIONTEC, INC. (Germany), Nano3D Biosciences, Inc.(U.S.), Cyfuse Biomedical K.K. (Tokyo), 3Dynamic Systems Ltd. (U.K), REGENHU (Switzerland), Poietis (France), and others.
3D Bioprinting Market - Competitive Analysis & News
In 3D Bioprinting, significant increase in the number of the companies offering various products including number of healthcare IT solutions leads rising emphasis on use of information technology for healthcare management. Product launch, mergers, acquisition and collaboration are major strategic approaches of these players to achieve growth in the market.
Different companies along with academic institutes and laboratories are investing a huge capital for 3D bioprinting research and development has supported the market growth. Key players in the market are involved in extensive R&D activities to use stem cells for bioprinting tissues, which drives the growth of this market. For instance, Materialise is one of the major player in this market. The company manufactures 3D bioprinters, and also undertakes 3D printing of anatomical models. In June 2017, Materialise improved 3D imaging and printing- clinical trials conducted in the U.S.
Organovo Holdings, Inc.
The company use 3D Bioprinting technology to create functional 3D human tissues for medical research, surgical, and therapeutic applications. It product "ExVive" is the 3D bioprinted human tissues, that is used in Organomics- the study of living organs in-vitro. Another product, NovoGen Bioprinter platform manufactured by the company is used for translating tissue specific geometries and cellular components.
In December, 2017, the company was granted orphan drug designation for the treatment of alpha-1 antitrypsin deficiency ("A1AT") with its 3D bioprinted liver therapeutic tissue by the U.S. Food and Drug Administration (FDA).
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/869 .
Materialise is one of the major players in the market. The company undertakes 3D printing of anatomical models and offers 3D bioprinters.
In June 2017, Materialise improved 3D imaging and printing- clinical trials conducted in the U.S.
In March 2017, Materialise declared FDA clearance for its 3D-printed patient-specific radius and ulna osteotomy guides for children. In May 2017, the company announced it would start the production of 3D bioprinter using technology-HP Jet Fusion 3D 4200.
3D Bioprinting Market - Segmentation
The global 3D bio-printing market is segmented on the basis of technology, material, application, and end users.
On the basis of the technology, the market is segmented into electron beam melting, laser beam melting, droplet disposition, syringe extrusion, magnetic levitation, and others. The laser beam melting segment is sub segmented into photo polymerization, stereo lithography, two-photon polymerization, and others. The droplet disposition segment is sub segmented into inkjet printing, fused disposition methods, multi-phase jet solidification, and others.
On the basis of the material, the market is segmented into cells, hydrogels, extracellular matrices, fibrinogen, alginate, and others.
On the basis of the application, the market is segmented into clinical, research, and others. The clinical segment is sub segmented into tissue transplantation, bone grafts, vascular grafts, wound care, and others. The wound care segment, by application, is further segmented into acute wounds, chronic wounds, hernia repair, and others. The research segment is sub-segmented into regenerative medicine, personalized healthcare, 3D cell culture, and others.
On the basis of the end users, the market is segmented into pharmaceutical & biotechnology companies, research organization, academic institutes, and others.
To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/869 .
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.2 Scope of the Study
2.2.1 Research Objective
Chapter 3. Research Methodology
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.